Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 12.94
+0.26 (2.05%)
At close: Oct 14, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 602.2 million as of October 14, 2026. It is the 28,947th most valuable company in the world and the 369th biggest in Sweden. Its market cap has decreased by 21.86% in one year.
Market Cap
602.20M
Enterprise Value
268.96M
Revenue
35.18M
Global Rank
Country Rank
#369 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 602.20M, a decrease of -60.31%. That is a compound annual growth rate of -32.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 602.20M | -32.81% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 2.10B |
| Cereno Scientific AB | 1.24B |
| Dicot Pharma AB | 860.23M |
| EQL Pharma AB | 655.56M |
| Moberg Pharma AB | 539.75M |
| Enzymatica AB | 426.00M |
| Orexo AB | 239.07M |
| Klaria Pharma Holding AB (publ.) | 130.12M |